Osteomyelitis Global Clinical Market Research Report, Analysis, Opportunities, Forecast, Revenue, Trends, Value : Ken Research

1

• Science Behind Osteomyelitis And Its Prevention
  Market Outlook Ken Research

2

• According to the study OSTEOMYELITIS GLOBAL
  CLINICAL TRIALS REVIEW, H1, 2018, this infection
  is usually treated with antibiotics given into
  veins or through surgery.
• Osteomyelitis is an infection of a bone caused by
  bacteria, mostly Staphylococcus aureus. It is
  pretty rare and certain chronic conditions like
  diabetes tend to increase the risk of
  osteomyelitis. It results in pain and redness
  around the affected region apart from symptoms
  like fever, nausea and chills. The disease can
  easily be diagnosed by X-ray, CT scan and blood
  tests. There are currently many advances being
  made in surgical treatment and medicine which are
  incorporating technology and research. The result
  of these advances in surgical treatment and
  antibiotic therapy is opening doors for various
  treatment options of osteomyelitis. The barriers
  to proper treatment are being studied in order to
  better understand the ways to intrude them. This
  can be proven by the developments that have taken
  place in osteomyelitis treatment such as the
  study carried out by research teams. An Institut
  Pasteur-CNRS research team has characterized a
  Staphylococcus aureus gene involved in virulence,
  bio film formation and resistance to certain
  antibiotics.

3

• Since osteomyelitis is mainly an infection, it
  can easily flourish around open wounds and
  recently treated areas around bones. New
  technologies for the prevention of healthcare
  associated infections are increasingly being
  developed and marketed to healthcare centers
  worldwide. This comes due to the realization of
  the fact that while there is substantial promise
  in simulated test environments, decreasing
  infections in the clinical setting has not been
  well established. There are a number of factors
  that raise concern in this respect, the most
  common ones being cross transmission in the
  hospital environment arising from contamination
  of hospital surfaces, contamination of medical
  devices and hands or clothes of medical
  personnel. Studies too show the alarming
  situation as more than one-third of hospital
  acquired infections are caused by contamination
  of medical workers hands. A patient admitted to
  a hospital room in which the previous occupant
  had methicillin-resistant Staphylococcus aureus
  has a significantly increased risk of acquiring
  the pathogens.

4

• In response to the crippling situation, there
  have been a number of developments like the use
  of Adenosine triphosphate (ATP) levels and
  fluorescent markers to monitor the microbial
  contamination levels. Manual cleaning remains an
  important precursor step as gross organic soil
  must be removed from surfaces to allow
  penetration of germicidal vapour/aerosol or
  radiation emitted from hydrogen peroxide or UV
  light emitting devices. Several antimicrobial
  coatings are under pre-clinical study for their
  potential application to surfaces in healthcare
  centers. However, Coatings copper has been
  studied most extensively.
• Antibiotics are increasingly undergoing research
  to increase their effectiveness. Many
  pharmaceutical companies are incorporating
  existing knowledge and expertise in their
  experiments in an order to expand their scope.
  Osteomyelitis among other ailments is providing
  opportunities to the pharmaceutical research
  sector to tackle microbial attacks. There is
  growing awareness about prevention of
  accelerating factors like hygiene and
  technologies like hand hygiene monitoring systems
  and antimicrobial textiles among others are said
  to help change the scenario.

5

• To know more, click on the link below
• https//www.kenresearch.com/healthcare/pharmaceuti
  cals/osteomyelitis-global-clinical-trials-h1-2018/
  149598-91.html
• Contact Us
• Ken Research
• Ankur Gupta, Head Marketing Communications
• sales_at_kenresearch.com
• 91-9015378249

6
(No Transcript)